Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 45 Endometrial Neoplasms 10 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 3 Neoplasms 3 Neoplasm Metastasis 3 Fallopian Tube Neoplasms 3 Progesterone Resistance 2 HR+/HER2- Breast Cancer 2 HR Positive HER2 Negative Advanced Breast Cancer 2 Endometrial Hyperplasia 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Neoplasms, Male 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Peritoneal Neoplasms 1 Pathologic Complete Response 1 Obesity 1 Neoplasms by Site 1 Low-Grade Serous Ovarian Cancer 1 Low Grade Serous Ovarian Carcinoma 1 Low Grade Serous Ovarian Cancer 1 Locoregional Recurrence 1 Leiomyoma 1 Infertility, Female 1 Infertility 1

Interventions

ribociclib 1 exemestane 1 Letrozole 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Locoregional Recurrence × Letrozole × Clear all

NCT05467891 2026-04-08

RaPhLRR

Hoosier Cancer Research Network

Phase 2 Recruiting

Locoregional Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡